Skip navigation

Disease Brain Diseases

These diseases have comparable sets of interacting chemicals and genes to Brain Diseases.

Via chemical associations

Similarity Index Common
Interacting
Chemicals
Nervous System Diseases 0.19731 0.19731 88
Brain Injuries 0.17485 0.17485 57
Coma 0.16435 0.16435 59
Confusion 0.15989 0.15989 59
Cognition Disorders 0.15974 0.15974 73
Nerve Degeneration 0.15574 0.15574 76
Ataxia 0.15443 0.15443 61
Central Nervous System Diseases 0.15361 0.15361 49
Vision Disorders 0.15291 0.15291 50
Renal Insufficiency 0.15 0.15 75
Movement Disorders 0.14898 0.14898 66
Memory Disorders 0.14583 0.14583 77
Neurotoxicity Syndromes 0.14573 0.14573 58
Peripheral Nervous System Diseases 0.14423 0.14423 60
Hallucinations 0.14421 0.14421 61
Status Epilepticus 0.14404 0.14404 52
Psychoses, Substance-Induced 0.14402 0.14402 53
Vomiting 0.14379 0.14379 88
Drug-Related Side Effects and Adverse Reactions 0.14184 0.14184 100
Fever 0.13793 0.13793 72

Via marker/mechanism chemical associations

Similarity Index Common
Interacting
Chemicals
Nervous System Diseases 0.19634 0.19634 75
Cognition Disorders 0.1728 0.1728 61
Coma 0.16049 0.16049 52
Nerve Degeneration 0.15805 0.15805 55
Memory Disorders 0.15804 0.15804 58
Neurotoxicity Syndromes 0.1571 0.1571 52
Central Nervous System Diseases 0.15548 0.15548 44
Confusion 0.15543 0.15543 53
Learning Disorders 0.1517 0.1517 49
Fever 0.15116 0.15116 65
Renal Insufficiency 0.14512 0.14512 64
Drug-Related Side Effects and Adverse Reactions 0.14184 0.14184 80
Peripheral Nervous System Diseases 0.14124 0.14124 50
Brain Injuries 0.14118 0.14118 36
Vomiting 0.13971 0.13971 76
Vision Disorders 0.13953 0.13953 42
Movement Disorders 0.13928 0.13928 50
Ataxia 0.13889 0.13889 50
Thrombocytopenia 0.13874 0.13874 53
Muscle Weakness 0.13861 0.13861 42

Via therapeutic chemical associations

Similarity Index Common
Interacting
Chemicals
Cataract 0.125 0.125 6
Movement Disorders 0.10156 0.10156 13
Alcohol Withdrawal Delirium 0.1 0.1 4
Dystonia 0.1 0.1 8
Muscle Cramp 0.09804 0.09804 5
Prenatal Exposure Delayed Effects 0.09804 0.09804 5
Paresis 0.09524 0.09524 4
Muscle Rigidity 0.09375 0.09375 9
Drug-Related Side Effects and Adverse Reactions 0.08889 0.08889 16
Basal Ganglia Diseases 0.08772 0.08772 5
Catatonia 0.08571 0.08571 6
Confusion 0.08511 0.08511 4
Hypokinesia 0.08434 0.08434 7
Amyotrophic Lateral Sclerosis 0.08333 0.08333 4
Brain Injuries 0.08333 0.08333 8
Cardiovascular Abnormalities 0.08333 0.08333 3
Speech Disorders 0.08333 0.08333 3
Neural Tube Defects 0.08 0.08 4
Brain Infarction 0.07843 0.07843 4
Coma 0.07843 0.07843 4

Via gene associations

Similarity Index Common
Interacting
Genes
Tuberous Sclerosis 0.12 0.12 3
Cognition Disorders 0.09091 0.09091 5
Occupational Diseases 0.09091 0.09091 3
Nerve Degeneration 0.08333 0.08333 9
Trichuriasis 0.08 0.08 2
Tuberous Sclerosis 2 0.08 0.08 2
Urticaria 0.07895 0.07895 3
Focal cortical dysplasia of Taylor 0.07692 0.07692 2
Hyperammonemia 0.07143 0.07143 2
Lymphangioleiomyomatosis 0.07143 0.07143 2
Epilepsy 0.07 0.07 7
Respiratory Tract Diseases 0.06897 0.06897 2
Spasms, Infantile 0.06897 0.06897 2
Dementia 0.06452 0.06452 2
Arthritis, Experimental 0.0625 0.0625 4
Pleural Diseases 0.06061 0.06061 2
Heart Diseases 0.05882 0.05882 4
Hyperplasia 0.05882 0.05882 3
Pulmonary Emphysema 0.05882 0.05882 2
Hepatitis B 0.05556 0.05556 3

Via marker/mechanism gene associations

Similarity Index Common
Interacting
Genes
Cognition Disorders 0.1 0.1 5
Occupational Diseases 0.09677 0.09677 3
Tuberous Sclerosis 0.08696 0.08696 2
Focal cortical dysplasia of Taylor 0.08333 0.08333 2
Urticaria 0.08333 0.08333 3
Nerve Degeneration 0.07792 0.07792 6
Epilepsy 0.07692 0.07692 7
Hyperammonemia 0.07692 0.07692 2
Lymphangioleiomyomatosis 0.07692 0.07692 2
Spasms, Infantile 0.07407 0.07407 2
Dementia 0.06897 0.06897 2
Hyperplasia 0.06667 0.06667 3
Arthritis, Experimental 0.05263 0.05263 3
Liver Failure, Acute 0.05263 0.05263 2
Retinal Degeneration 0.05263 0.05263 2
Hepatitis, Chronic 0.04762 0.04762 2
Nephrotic Syndrome 0.04762 0.04762 2
Developmental Disabilities 0.04545 0.04545 2
Seizures 0.04425 0.04425 5
Amyloidosis, Cerebroarterial, App-Related 0.04348 0.04348 1
Camurati-Engelmann Syndrome 0.04348 0.04348 1
Cholestasis, Extrahepatic 0.04348 0.04348 2
Cognitive Dysfunction 0.04348 0.04348 1
CORTICAL MALFORMATIONS, OCCIPITAL 0.04348 0.04348 1
Dicarboxylicaminoaciduria 0.04348 0.04348 1
Epilepsy, Benign Neonatal 0.04348 0.04348 1
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7 0.04348 0.04348 1
Gastric Antral Vascular Ectasia 0.04348 0.04348 1
HIV Seropositivity 0.04348 0.04348 1
Hypersensitivity, Delayed 0.04348 0.04348 1
Hyperthyroxinemia, Familial Dysalbuminemic 0.04348 0.04348 1
Leukoencephalopathy, Cystic, Without Megalencephaly 0.04348 0.04348 1
Low Tension Glaucoma 0.04348 0.04348 1
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME 0.04348 0.04348 1
Myeloperoxidase Deficiency 0.04348 0.04348 1
Opisthorchiasis 0.04348 0.04348 1
Ornithine Carbamoyltransferase Deficiency Disease 0.04348 0.04348 1
ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO 0.04348 0.04348 1
Penile Induration 0.04348 0.04348 1
Peritoneal Fibrosis 0.04348 0.04348 1
Posterior Leukoencephalopathy Syndrome 0.04348 0.04348 1
Rhinitis, Allergic, Perennial 0.04348 0.04348 1
SEIZURES, BENIGN FAMILIAL NEONATAL, 1 0.04348 0.04348 1
Serum Sickness 0.04348 0.04348 1
Tuberous Sclerosis 1 0.04348 0.04348 1
Vasculopathy, Retinal, With Cerebral Leukodystrophy 0.04348 0.04348 1
ZINC, ELEVATED PLASMA 0.04348 0.04348 1

Via therapeutic gene associations